| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|---|---|
| Fc gamma RIV / CD16-2 | Mouse Fc gamma RIV / CD16-2 Protein, His Tag (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $245.00 50ug | |||
| Fc gamma RIV / CD16-2 | Avitag FC4-M82E8 | Biotinylated Mouse Fc gamma RIV / CD16-2 Protein, His,Avitag™ (HPLC & BLI verified) | Mouse | HEK293 | ![]() | HPLCSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Cepeprubart | SelK-2 | Phase 2 Clinical | Selexys | Venous Thromboembolism; Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| Leiolizumab | AbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268 | Phase 2 Clinical | Altrubio Inc | Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| Neihulizumab | AbGn-168; AbGn-168H; ALTB-168 | Phase 1 Clinical | Altrubio Inc | Graft vs Host Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic | Details |
| SSGJ-617 | SSGJ-617; SSGJ617; 61X; VTX-0811; 617 | Phase 1 Clinical | Verseau Therapeutics Inc | Solid tumours | Details |

